Image by Flybynight on Pixabay · Pixabay License
Sarah Gilbert
Sign in to saveAlso known as Sarah C. Gilbert, Sarah C Gilbert, S. C. Gilbert, S C Gilbert, S. Gilbert, S Gilbert, Gilbert, Gilbert S
British vaccinologist
Person · Open Library
- Works
- 27
Top works
- Lonely Planet Costa Rica
- Makeup Like a Pro
- Eye Shadow Techniques
- Tale of My Tail
- Hello, at Last
via Open Library + Wikidata
Key facts
- Born
- April 1962 (age 64), Kettering, Northamptonshire , England
- Alma mater
- University of East Anglia (BSc), University of Hull (PhD)
- Known for
- Vaccinology
- Awards
- Albert Medal (2021), Princess of Asturias Award (2021), King Faisal Prize (2023)
- Fields
- Vaccines
- Institutions
- University of Oxford , Vaccitech , Delta Biotechnology, Leicester Biocentre, Brewing Industry Research Foundation , Christ Church, Oxford
- Thesis
- Studies on lipid accumulation and genetics of Rhodosporidium toruloides (1986)
- Doctoral advisor
- Colin Ratledge , Dr M. Keenan
- Website
- www .jenner .ac .uk /team /sarah-gilbert
via Wikipedia infobox
Wikidata facts
- Instance of
- human
- Given name
- Catherine
- Family name
- Gilbert
- Gender
- female
- Citizenship
- United Kingdom
- Place of birth
- Kettering
- Occupation
- immunologist
- Educated at
- University of East Anglia
- Employer
- University of Oxford
- Languages spoken
- English language
- Instrument
- saxophone
- Official website
- www.jenner.ac.uk/team/sarah-gilbert
- Image
- Dr.Sarah Gilbert.jpg
- Number of children
- 3
Show 4 more facts
- on focus list of Wikimedia project
- BBC 100 Women Edit-a-thon
- date of birth
- 1962-04-03
- name in native language
- Sarah Catherine Gilbert
- Commons category
- Sarah Catherine Gilbert
Sources (8)
via Wikidata · CC0
~13 min read
Encyclopedic overview
Dame Sarah Catherine Gilbert (born April 1962) is an English vaccinologist who is a Professor of Vaccinology at the University of Oxford and co-founder of Vaccitech. She specialises in the development of vaccines against influenza and emerging viral pathogens. She led the development and testing of the universal flu vaccine, which underwent clinical trials in 2011.
In January 2020, she read a report on ProMED-mail about four people in China suffering from a strange kind of pneumonia of unknown origin in Wuhan. Within two weeks, a vaccine had been designed at Oxford against the new pathogen, which later became known as COVID-19. On 30 December 2020, the Oxford–AstraZeneca COVID-19 vaccine she co-developed with the Oxford Vaccine Group was approved for use in the UK. More than 3 billion doses of the vaccine were supplied to countries worldwide.
Excerpted from Wikipedia’s “Sarah Gilbert” article, available under the CC BY-SA 4.0 licence.